### Details

**Title:** [Cloning-Censor-Weighting study](link)

**Authors:** Martí Catalá<sup>1</sup>

**Affiliations:** <sup>1</sup>Health Data Sciences, NDORMS, University of Oxford.

**Corresponding:** [marti.catalasabate\@ndorms.ox.ac.uk](mailto:marti.catalasabate@ndorms.ox.ac.uk)

<div style="text-align: center;">
  <img src="hds_logo.svg" alt="HDS Logo" height="70" style="vertical-align: middle; margin-right: 10px;">
  <img src="oxford.png" alt="Oxford Logo" height="70" style="vertical-align: middle;">
</div>

### Abstract

### Methods

<div style="text-align: center;">
  <div style="display: inline-block; text-align: center;">
    <img src="diagram.png" alt="Diagram" height="400" style="vertical-align: middle;">
    <div style="text-align: center; font-style: italic; margin-top: 8px; max-width: 600px;">
      <strong>Figure 1.</strong> Study design. Index date for the three cohorts is the first diagnostics
      of prostate cancer. All cohorts are censored at death/end observation*. Surveillance cohort is 
      censored if they have an occurrence of *radiotherapy* or *prostatectomy*. Radiotherapy cohort is 
      censored if they have an occurrence of *prostatectomy* or after 365 if no occurrence of *radiotherapy*
      is recorded. Prostatectomy cohort is censored if they have an occurrence of *radiotherapy* or after 
      365 if no occurrence of *prostatectomy* is recorded. Outcomes events are observed if they occure before
      or at the date of censoring.
    </div>
  </div>
</div>

### Results

### Conclusions
